Smac mimetic LCL161 supports neuroblastoma chemotherapy in a drug class-dependent manner and synergistically interacts with ALK inhibitor TAE684 in cells with ALK mutation F1174L

Neuroblastoma is the most common extracranial solid tumor during infancy and childhood. Outcome of high-risk and late-stage disease remains poor despite intensive treatment regimens. Suppressing inhibitor of apoptosis proteins (IAPs) using Smac mimetics (SM) significantly sensitizes neuroblastoma (N...

Descripción completa

Detalles Bibliográficos
Autores principales: Najem, Safiullah, Langemann, Doerte, Appl, Birgit, Trochimiuk, Magdalena, Hundsdoerfer, Patrick, Reinshagen, Konrad, Eschenburg, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341933/
https://www.ncbi.nlm.nih.gov/pubmed/27655666
http://dx.doi.org/10.18632/oncotarget.12055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341933/
https://www.ncbi.nlm.nih.gov/pubmed/27655666
http://dx.doi.org/10.18632/oncotarget.12055

Ejemplares similares